Dr. Wenfeng Yang 杨文锋
Chief Physician
Thoracic Surgery, Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital), Jinan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of esophageal cancer, cardia cancer, lung cancer, and mediastinal tumors.
Dr. Yang is Chief Physician and Deputy Director of Thoracic Surgery at Shandong Cancer Hospital. Holding a PhD from Shandong University and postdoctoral training from Tianjin Medical University, Dr. Yang has nearly 20 years of clinical experience in thoracic surgery. Dr. Yang serves as a master’s supervisor and has participated in four research projects, including one National Natural Science Foundation grant. Over 20 papers have been published.
Professional roles
- Guest Reviewer, Chinese Journal of Clinical Oncology
- Guest Reviewer, Chinese Journal of Lung Cancer
Name order: in Chinese the family name comes first (Yang Wenfeng). Papers usually list the name as Wenfeng Yang or Yang W.
Selected publications
18 papers on PubMed matched by name and affiliation; 4 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Imaging, 2026 (senior author): (18)F-FDG PET/CT metabolic parameter to predict pathological complete response and survival after neoadjuvant immunotherapy plus chemoradiotherapy in resectable esophageal squamous cell carcinoma. PubMed 42754907
- Transl Lung Cancer Res, 2024 (senior author): Construction and validation of a prognostic model based on oxidative stress-related genes in non-small cell lung cancer (NSCLC): predicting patient outcomes and therapy responses. PubMed 39669999
- Thorac Cancer, 2023 (senior author): Update on therapeutic strategy for esophageal anastomotic leak: A systematic literature review. PubMed 36524684
- J Cell Biochem, 2019 (senior author): CircABCB10 promotes nonsmall cell lung cancer cell proliferation and migration by regulating the miR-1252/FOXR2 axis. PubMed 30417418
- Eur J Nucl Med Mol Imaging, 2012 (first author): Imaging proliferation of ¹⁸F-FLT PET/CT correlated with the expression of microvessel density of tumour tissue in non-small-cell lung cancer. PubMed 22581165
- Eur J Nucl Med Mol Imaging, 2010 (first author): Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer. PubMed 20309686
- Zhonghua Zhong Liu Za Zhi, 2009 (first author): [Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer]. PubMed 20193335
- Lung Cancer, 2008 (first author): Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer. PubMed 18177978
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion